Stimuli-responsive doxorubicin-loading Zr-MOF film for time-ordered tumor therapy and bone regeneration. (1st February 2023)
- Record Type:
- Journal Article
- Title:
- Stimuli-responsive doxorubicin-loading Zr-MOF film for time-ordered tumor therapy and bone regeneration. (1st February 2023)
- Main Title:
- Stimuli-responsive doxorubicin-loading Zr-MOF film for time-ordered tumor therapy and bone regeneration
- Authors:
- Yan, Bangcheng
Tan, Ji
Chen, Lan
Zhang, Haifeng
Ma, Xiaohan
Qiao, Yuqin
Liu, Xuanyong - Abstract:
- Abstract: The recurrence of bone tumors in the early stage and poor osseointegration in the late stage are the main challenges in the clinical treatment of osteosarcoma. Thus, developing a bone implant with time-ordered anti-tumor and osteogenic abilities may be a promising strategy for osteosarcoma therapy. Here, we constructed a NIR and H2 O2 dual-responsive Zr-MOF film composed of Zr ions and ferrocene on the titanium and then loaded the anti-tumor drug doxorubicin (DOX) by electrostatic interaction. Under the stimulation of H2 O2 in the tumor microenvironment, the Fe 2+ in this Zr-MOF film transformed to Fe 3+, which could reduce the negative charge of the Zr-MOF to release DOX. Besides, this drug-loading Zr-MOF film possessed good photothermal conversion capability, which enabled the rapid synthetic anti-tumor effect of chemotherapy and photothermal therapy in the initial stage by using NIR irradiation. In vitro results confirmed that the drug-loading Zr-MOF film exhibited good anti-tumor performance against two kinds of human osteosarcoma cells (Saos-2 and 143B cells), which could be further enhanced by using NIR irradiation, and it also showed good anti-tumor properties in vivo . On the other hand, this Zr-MOF film became super hydrophilic after tumor treatment and then promoted the adhesion and the expression of osteogenic genes (ALP, Col-I, TGF-β, and Runx2) of bone cells. This study provides new sight into the design of bone implants with time-ordered tumor therapyAbstract: The recurrence of bone tumors in the early stage and poor osseointegration in the late stage are the main challenges in the clinical treatment of osteosarcoma. Thus, developing a bone implant with time-ordered anti-tumor and osteogenic abilities may be a promising strategy for osteosarcoma therapy. Here, we constructed a NIR and H2 O2 dual-responsive Zr-MOF film composed of Zr ions and ferrocene on the titanium and then loaded the anti-tumor drug doxorubicin (DOX) by electrostatic interaction. Under the stimulation of H2 O2 in the tumor microenvironment, the Fe 2+ in this Zr-MOF film transformed to Fe 3+, which could reduce the negative charge of the Zr-MOF to release DOX. Besides, this drug-loading Zr-MOF film possessed good photothermal conversion capability, which enabled the rapid synthetic anti-tumor effect of chemotherapy and photothermal therapy in the initial stage by using NIR irradiation. In vitro results confirmed that the drug-loading Zr-MOF film exhibited good anti-tumor performance against two kinds of human osteosarcoma cells (Saos-2 and 143B cells), which could be further enhanced by using NIR irradiation, and it also showed good anti-tumor properties in vivo . On the other hand, this Zr-MOF film became super hydrophilic after tumor treatment and then promoted the adhesion and the expression of osteogenic genes (ALP, Col-I, TGF-β, and Runx2) of bone cells. This study provides new sight into the design of bone implants with time-ordered tumor therapy and bone regeneration abilities in practical clinical applications. Highlights: A H2 O2 and NIR dual-responsive DOX-loaded Zr-MOF film was constructed on titanium. This Zr-MOF film possess time-ordered anti-tumor and osteogenic properties. A good anti-tumor effect was achieved under the synthetic photothermal/chemo-therapy. This Zr-MOF film became hydrophilic after treating tumor to enhance bone formation. … (more)
- Is Part Of:
- Composites. Number 250(2022)
- Journal:
- Composites
- Issue:
- Number 250(2022)
- Issue Display:
- Volume 250, Issue 250 (2022)
- Year:
- 2022
- Volume:
- 250
- Issue:
- 250
- Issue Sort Value:
- 2022-0250-0250-0000
- Page Start:
- Page End:
- Publication Date:
- 2023-02-01
- Subjects:
- Metal-organic framework -- Anti-tumor -- Osteogenesis -- Time-ordered -- Stimuli-responsive
Composite materials -- Periodicals
Materials science -- Periodicals
Composite materials
Periodicals
Electronic journals
620.118 - Journal URLs:
- http://www.sciencedirect.com/science/journal/13598368 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.compositesb.2022.110452 ↗
- Languages:
- English
- ISSNs:
- 1359-8368
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3365.620000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 25060.xml